EP4098301A1 — Breath actuated inhaler
Assigned to Norton Waterford Ltd · Expires 2022-12-07 · 3y expired
What this patent protects
A metered dose inhaler and in particular, a breath actuated metered dose inhaler, providing a valve port (1095) and a diaphragm (1000) for a pneumatic force holding unit of a breath actuated metered dose inhaler, a flap valve (36) for the canister fire system of a breath actuated…
USPTO Abstract
A metered dose inhaler and in particular, a breath actuated metered dose inhaler, providing a valve port (1095) and a diaphragm (1000) for a pneumatic force holding unit of a breath actuated metered dose inhaler, a flap valve (36) for the canister fire system of a breath actuated metered dose inhaler, as well as methods for manufacturing and assembling the same. The valve port further comprises an annular boss (1100) defining a valve orifice channel (78), two or more radially outwardly extending projections (1106, 1107) defining a path through which polymer passed to form the boss during injection moulding, wherein the radially outwardly extending projections are substantially uniformly circumferentially separated, preferably wherein the boss has a longitudinal axis (X) which passes through the valve orifice channel, and wherein two radially outwardly extending projections and the valve orifice channel lie in a common plane coincident with the longitudinal axis.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.